Keywords: پپتید 1-گلوکاگون (GLP-1); Diabetes; Glucagon-like peptide-1 (GLP-1); mimetics; Dipeptidil peptidase-4 (DPP-4); antagonists; Sodium glucose co-transporter-2 (SGLT-2); antagonists; Pioglitazone; Rosiglitazone;
مقالات ISI پپتید 1-گلوکاگون (GLP-1) (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پپتید 1-گلوکاگون (GLP-1); Dogfish glucagon; Glucagon-like peptide-1 (GLP-1); Glucose dependent insulinotropic polypeptide (GIP); Glucagon; Dual agonist; Diabetes; Acute effects; Antidiabetic and antihyperglycaemic
Keywords: پپتید 1-گلوکاگون (GLP-1); Gastrin; Glucagon-like peptide-1 (GLP-1); NCI-H716 cell line; Cholecystokinin2 receptor (CCK2R); Rat colon
Keywords: پپتید 1-گلوکاگون (GLP-1); Platform comparison; ELISA; MSD; Gyrolab; Singulex; Glucagon-like peptide-1 (GLP-1);
Keywords: پپتید 1-گلوکاگون (GLP-1); Glucagon-like peptide-1 (GLP-1); Peptide tyrosine tyrosine (PYY); Ghrelin; Gastric emptying; Stomach;
Keywords: پپتید 1-گلوکاگون (GLP-1); Cognitive function; Glucagon-like peptide-1 (GLP-1); Hippocampus; Lixisenatide;
Keywords: پپتید 1-گلوکاگون (GLP-1); DAPI; 4â²,6-diamidino-2-phenylindole; EIA; enzyme-linked immunoassay; GLP-1; glucagon-like peptide-1; GluOC; uncarboxylated osteocalcin; IPGTT; intraperitoneal glucose tolerance test; OGTT; oral glucose tolerance test; PCNA; proliferating cell nuclear an
Cholecystokinin (CCK) and related adjunct peptide therapies for the treatment of obesity and type 2 diabetes
Keywords: پپتید 1-گلوکاگون (GLP-1); Cholecystokinin (CCK); Glucagon-like peptide-1 (GLP-1); Glucose-dependent insulinotropic polypeptide (GIP); Amylin; Leptin; Insulin secretion; Satiety; Obesity; Diabetes;
Targeted intestinal delivery of incretin secretagogues-towards new diabetes and obesity therapies
Keywords: پپتید 1-گلوکاگون (GLP-1); Enteroendocrine hormones; peptideYY (PYY); Glucagon-like peptide-1 (GLP-1); Diabetes; Obesity; Capsules; Pellets; Infusion;
Co-storage and release of insulin-like peptide-5, glucagon-like peptide-1 and peptideYY from murine and human colonic enteroendocrine cells
Keywords: پپتید 1-گلوکاگون (GLP-1); Insulin-like peptide-5 (INSL5); Glucagon-like peptide-1 (GLP-1); peptideYY (PYY); Enteroendocrine; L-cell; LC-MS; Human colonic cultures; 3D-SIM;
Electroacupuncture for functional dyspepsia and the influence on serum Ghrelin, CGRP and GLP-1 levels
Keywords: پپتید 1-گلوکاگون (GLP-1); Functional dyspepsia; Electroacupuncture; Ghrelin; Calcitonin gene-related peptide (CGRP); Glucagon-like peptide-1 (GLP-1);
The glucagon-like peptide-1 analogue liraglutide promotes autophagy through the modulation of 5â²-AMP-activated protein kinase in INS-1 β-cells under high glucose conditions
Keywords: پپتید 1-گلوکاگون (GLP-1); Glucagon-like peptide-1 (GLP-1); 5â²-AMP-activated protein kinase (AMPK); Autophagy; Pancreatic β-cells; High glucose;
Oleoyl-lysophosphatidylinositol enhances glucagon-like peptide-1 secretion from enteroendocrine L-cells through GPR119
Keywords: پپتید 1-گلوکاگون (GLP-1); GLP-1; glucagon-like peptide-1; GPCR; G protein-coupled receptor; Oleoyl-LPI; Oleoyl-lysophosphatidylinositol; T2D; type 2 diabetes; Lysophosphatidylinositol (LPI); Glucagon-like peptide-1 (GLP-1); GPR119; GPR55; L-cells; Mixed colonic preparation;
Effects of the Novel Long-Acting GLP-1 Agonist, Albiglutide, on Cardiac Function, Cardiac Metabolism, and Exercise Capacity in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Keywords: پپتید 1-گلوکاگون (GLP-1); albiglutide; glucagon-like peptide-1 (GLP-1); heart failure; 6MW; 6-minute-walk test; AE; adverse event; CT; computed tomography; GLP; glucagon-like peptide; HFrEF; heart failure with reduced ejection fraction; LV; left ventricular; LVEF; left ventricular
Peptide-based GLP-1/glucagon co-agonists: A double-edged sword to combat diabesity
Keywords: پپتید 1-گلوکاگون (GLP-1); Diabesity; Glucagon-like peptide-1 (GLP-1); Glucagon; Oxyntomodulin; Co-agonist;
New screening strategy and analysis for identification of allosteric modulators for glucagon-like peptide-1 receptor using GLP-1 (9-36) amide
Keywords: پپتید 1-گلوکاگون (GLP-1); G-protein-coupled receptor (GPCR); β-arrestin; Receptor internalization; Glucagon-like peptide-1 (GLP-1); Positive allosteric modulator (PAM); High-throughput screening (HTS)GLP-1, glucagon-like peptide 1; GLP-1R, glucagon-like peptide 1 receptor; DM, dia
Comparison of the independent and combined effects of sub-chronic therapy with metformin and a stable GLP-1 receptor agonist on cognitive function, hippocampal synaptic plasticity and metabolic control in high-fat fed mice
Keywords: پپتید 1-گلوکاگون (GLP-1); Cognitive function; Glucagon-like peptide-1 (GLP-1); Hippocampus; Long-term potentiation (LTP); Metformin;
GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance
Keywords: پپتید 1-گلوکاگون (GLP-1); Glucagon-like peptide-1 (GLP-1); Very low density lipoprotein (VLDL); Fasting dyslipidemia; Insulin resistance; Hepatic steatosis; IncretinapoB100, apolipoproteinB100; FFA, free fatty acid; GLP-1, glucagon-like peptide-1; GLP-1R, GLP-1 receptor; ICV, intr
A novel GIP-oxyntomodulin hybrid peptide acting through GIP, glucagon and GLP-1 receptors exhibits weight reducing and anti-diabetic properties
Keywords: پپتید 1-گلوکاگون (GLP-1); Glucose-dependent insulinotropic polypeptide (GIP); Glucagon-like peptide-1 (GLP-1); Oxyntomodulin (OXM); Obesity-diabetes; Insulin secretion
Gastrointestinal factors contribute to glucometabolic disturbances in nondiabetic patients with end-stage renal disease
Keywords: پپتید 1-گلوکاگون (GLP-1); end-stage renal disease (ESRD); gastrointestinal-mediated glucose disposal (GIGD); glucagon; glucagon-like peptide-1 (GLP-1); glucose-dependent insulinotropic polypeptide (GIP); incretin effect
Circulating ghrelin and GLP-1 are not affected by habitual diet
Keywords: پپتید 1-گلوکاگون (GLP-1); Macronutrients; Ghrelin; Glucagon-like peptide-1 (GLP-1)
Nutrient detection by incretin hormone secreting cells
Keywords: پپتید 1-گلوکاگون (GLP-1); Glucose-dependent insulinotropic polypeptide (GIP); Glucagon-like peptide-1 (GLP-1); Intestinal K-cells; Intestinal L-cells; Nutrient sensing;
Self-inducible secretion of glucagon-like peptide-1 (GLP-1) that allows MIN6 cells to maintain insulin secretion and insure cell survival
Keywords: پپتید 1-گلوکاگون (GLP-1); Glucagon-like peptide-1 (GLP-1); MIN6; Exendin-4; Insulin; Apoptosis; Autocrine;
Actions of incretin metabolites on locomotor activity, cognitive function and in vivo hippocampal synaptic plasticity in high fat fed mice
Keywords: پپتید 1-گلوکاگون (GLP-1); Cognitive function; Glucose-dependent insulinotropic polypeptide (GIP); GIP(3-42); Glucagon-like peptide-1 (GLP-1); GLP-1(9-36)amide; Long-term potentiation (LTP);
The role of gut hormones in controlling the food intake. What is their role in emerging diseases?
Keywords: پپتید 1-گلوکاگون (GLP-1); Gut hormones; Obesity; Glucagon-like peptide-1 (GLP-1); Non-alcoholic fatty liver disease (NAFLD); Cholecystokinin (CCK); Ghrelin; Peptide YY (PYY)Hormonas intestinales; Obesidad; Péptido-1 similar al glucagón (GLP-1); Esteatohepatitis no alcohólica (EHNA
The role of gut hormones in controlling the food intake. What is their role in emerging diseases?
Keywords: پپتید 1-گلوکاگون (GLP-1); Gut hormones; Obesity; Glucagon-like peptide-1 (GLP-1); Non-alcoholic fatty liver disease (NAFLD); Cholecystokinin (CCK); Ghrelin; Peptide YY (PYY); Hormonas intestinales; Obesidad; Péptido-1 similar al glucagón (GLP-1); Esteatohepatitis no alcohólica
Using the lymphatics to study nutrient absorption and the secretion of gastrointestinal hormones
Keywords: پپتید 1-گلوکاگون (GLP-1); Lymph; Lymph fistula rat model; Incretin; Chylomicron; Glucose-dependent insulinotropic polypeptide (GIP); Glucagon-like peptide-1 (GLP-1)
Identification of serum proteins involved in pancreatic cancer cachexia
Keywords: پپتید 1-گلوکاگون (GLP-1); Zinc-α2-glycoprotein (ZAG); Glucagon-like peptide-1 (GLP-1); Biomarker; Cachexia; Pancreatic cancer;
Glucagon-like peptide 1 protects microvascular endothelial cells by inactivating the PARP-1/iNOS/NO pathway
Keywords: پپتید 1-گلوکاگون (GLP-1); Glucagon-like peptide-1 (GLP-1); Islet microvascular endothelial cells; Oxidized low-density lipoprotein; PARP-1; iNOS; GLP-1 receptor;
Insulin-releasing and metabolic effects of small molecule GLP-1 receptor agonist 6,7-dichloro-2-methylsulfonyl-3-N-tert-butylaminoquinoxaline
Keywords: پپتید 1-گلوکاگون (GLP-1); Glucagon-like peptide-1 (GLP-1); Glucose homeostasis; Small molecule; Insulin secretion; Diabetes
Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptor
Keywords: پپتید 1-گلوکاگون (GLP-1); Glucagon-like peptide-1 (GLP-1); Exendin-4; Proliferation; Endothelial cell; GLP-1 receptor
Effects of long-term dipeptidyl peptidase-IV inhibition on body composition and glucose tolerance in high fat diet-fed mice
Keywords: پپتید 1-گلوکاگون (GLP-1); Dipeptidyl peptidase-IV (DPP-IV); DPP-IV inhibitor; Incretin; Glucagon-like peptide-1 (GLP-1); Gastric inhibitory polypeptide (GIP)
Antidiabetic effects of sub-chronic activation of the GIP receptor alone and in combination with background exendin-4 therapy in high fat fed mice
Keywords: پپتید 1-گلوکاگون (GLP-1); Glucose-dependent insulinotropic polypeptide (GIP); Glucagon-like peptide-1 (GLP-1); Exendin-4; Dipeptidyl peptidase IV (DPP IV); Glucose homeostasis; High fat feeding
Immunoassays for the incretin hormones GIP and GLP-1
Keywords: پپتید 1-گلوکاگون (GLP-1); radioimmunoassay (RIA); enzyme-linked immunosorbent assay (ELISA); glucagon-like peptide-1 (GLP-1); glucose-dependent insulinotropic polypeptide (GIP); incretin; dipeptidyl peptidase-4 (DPP-4)
The spectrum of antidiabetic actions of GLP-1 in patients with diabetes
Keywords: پپتید 1-گلوکاگون (GLP-1); glucagon-like peptide-1 (GLP-1); beta-cell function; type 2 diabetes mellitus; glucagon; antidiabetic; incretin hormones
Therapeutic potential for GIP receptor agonists and antagonists
Keywords: پپتید 1-گلوکاگون (GLP-1); incretin; glucose-dependent insulinotropic polypeptide (GIP); glucagon-like peptide-1 (GLP-1); obesity; type 2 diabetes; GIP antagonism; Roux-en-Y
Cardiovascular consequences of drugs used for the treatment of diabetes: potential promise of incretin—based therapies
Keywords: پپتید 1-گلوکاگون (GLP-1); Glucagon-like peptide-1 (GLP-1); ischemia-reperfusion injury; diabetes mellitus; insulin resistance
GLP-1 and related peptides cause concentration-dependent relaxation of rat aorta through a pathway involving KATP and cAMP
Keywords: پپتید 1-گلوکاگون (GLP-1); Glucagon-like peptide-1 (GLP-1); Exendin; Incretin; Hormone; Non-peptide agonist; Vasorelaxation; Aorta
Imidazopiperidine amides as dipeptidyl peptidase IV inhibitors for the treatment of diabetes
Keywords: پپتید 1-گلوکاگون (GLP-1); Dipeptidyl peptidase IV inhibitors; Diabetes; Glucagon-like peptide-1 (GLP-1); Incretin hormones; Imidazopiperidine amides
The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance
Keywords: پپتید 1-گلوکاگون (GLP-1); Diabetes mellitus; Chronic pancreatitis; Incretin hormones; Glucose-dependent insulinotropic polypeptide (GIP); Glucagon-like peptide-1 (GLP-1); Insulin
Islet neogenesis: A potential therapeutic tool in type 1 diabetes
Keywords: پپتید 1-گلوکاگون (GLP-1); Epithelial growth factor (EGF); Gastrin; Glucagon-like peptide-1 (GLP-1); Islet neogenesis associated protein (INGAP); Pancreatic plasticity; Stem cell therapy
Islet neogenesis: A potential therapeutic tool in type 1 diabetes
Keywords: پپتید 1-گلوکاگون (GLP-1); Epithelial growth factor (EGF); Gastrin; Glucagon-like peptide-1 (GLP-1); Islet neogenesis associated protein (INGAP); Pancreatic plasticity; Stem cell therapy
Synthesis, bioactivity and specificity of glucagon-like peptide-1 (7–37)/polymer conjugate to isolated rat islets
Keywords: پپتید 1-گلوکاگون (GLP-1); Glucagon-like peptide-1 (GLP-1); Polymer; Insulin secretion; Islets of Langerhans; Biohybrid artificial pancreas